ReproCell Akcija

ReproCell ROCE

Vrijednost ROCE (Return on Capital Employed) od ReproCell (4978.T) na dan 1. авг 2026. je -1,45 %. Prethodne godine, ROCE (Return on Capital Employed) je bio -4,92 % — promjena od -70,53% (viši).

ROCE

-1,45 %

YoY

-70,53%

Zadnja ažuriranja:

U godini 2026 rentabilnost uloženog kapitala (ROCE) kompanije ReproCell iznosila je -1,45 %, što je porast od -70,53% u poređenju sa -4,92 % ROCE prethodne godine.

Access this data via the Eulerpool API

ReproCell Анализа акција

Šta radi ReproCell? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell je jedna od najpopularnijih kompanija na Eulerpool.

ROCE у детаљу

Otkrivanje profitabilnosti upotrebljenog kapitala (ROCE) kompanije ReproCell

Profitabilnost upotrebljenog kapitala (ROCE) kompanije ReproCell je finansijski pokazatelj koji meri profitabilnost i efikasnost kompanije u pogledu uloženog kapitala. Izračunava se deljenjem dobiti pre kamata i poreza (EBIT) sa uloženim kapitalom. Viši ROCE ukazuje na to da kompanija efektivno koristi svoj kapital za stvaranje dobiti.

Godišnji poređenja

Godišnja analiza ROCE kompanije ReproCell pruža dragoceni uvid u njenu efikasnost korišćenja kapitala u svrhu ostvarivanja dobiti. Porast ROCE ukazuje na poboljšanu profitabilnost i operativnu efikasnost, dok pad može signalizirati moguće probleme u korišćenju kapitala ili poslovanju.

Utjecaj na investicije

ROCE kompanije ReproCell je ključni faktor za investitore i analitičare pri oceni efikasnosti i profitabilnosti kompanije. Viši ROCE može učiniti kompaniju privlačnom za ulaganje, jer često ukazuje na to da kompanija ostvaruje adekvatnu dobit iz svog uloženog kapitala.

Interpretacija fluktuacija ROCE

Promene u ROCE kompanije ReproCell su rezultat varijacija u EBIT-u ili upotrebljenom kapitalu. Te fluktuacije pružaju uvid u operativnu efikasnost, finansijsku izvedbu i strategijsko upravljanje finansijama kompanije i pomažu investitorima u donošenju informisanih odluka.

Često postavljena pitanja o akciji ReproCell

ROCE (Return on Capital Employed) kompanije ReproCell iznosi -1,45 % u 2026. godini.

Access this data via the Eulerpool API

Профитабилност — ReproCell

Sve ključne metrike — ReproCell

Раст